Showing 41-50 of 52 results for "".
- Open Enrollment Underway for Phase 2b Trial of Topical AMTX-100 CF3 in ADhttps://practicaldermatology.com/news/open-enrollment-underway-for-phase-2b-trial-of-topical-amtx-100-cf3-in-ad/2461827/Amytrx Therapeutics is enrolling mild to moderate atopic dermatitis patients for its Phase 2b clinical trial of a topical formulation of AMTX-100 CF3. Eligible adults interested in participating or learning more about the trial are encouraged to visit the
- COVID-19, the Stock Market, and Dermatologyhttps://practicaldermatology.com/news/covid-19-the-stock-market-and-dermatology/2460688/By Amylee Martin, BS, Akshitha Thatiparthi, BS, Jeffrey Liu, BS, Jashin J. Wu, MD Novel coronavirus, COVID-19, is not only a major public health threat but has also impacted the economy. Due to the pandemic, experts predict a 0.5% decrease in t
- Heather Peffleyhttps://practicaldermatology.com/profiles/heather-peffley/LqN41Q/
- Amy Klinkhttps://practicaldermatology.com/profiles/amy-klink/OE6nYP/
- Heather A. Brandling-Bennett, MDhttps://practicaldermatology.com/profiles/heather-a-brandling-bennett-md/OXX4ZP/
- Amy McMichael, MDhttps://practicaldermatology.com/profiles/amy-mcmichael-md/LDGQpg/
- Amy Brodsky, MD, FAADhttps://practicaldermatology.com/profiles/amy-brodsky-md-faad/L6KQXq/
- Amy Lewis, MDhttps://practicaldermatology.com/profiles/amy-lewis-md/jG8EV9/
- Amy Forman Taub, MDhttps://practicaldermatology.com/profiles/amy-forman-taub-md/Lx5pm8/
- Amy Paller, MDhttps://practicaldermatology.com/profiles/amy-paller-md/Ld9Gl9/